Subject(s)
Abortifacient Agents, Nonsteroidal/therapeutic use , Abortion, Criminal/adverse effects , Abortion, Induced/methods , Abortion, Induced/standards , Ambulances/economics , Delivery of Health Care/organization & administration , Delivery of Health Care/standards , Emergency Medical Services/economics , Emergency Medical Services/organization & administration , Fees and Charges/statistics & numerical data , Geographic Information Systems , Health Services Accessibility/trends , Maternal Health Services/economics , Maternal Health Services/organization & administration , Misoprostol/therapeutic use , Models, Organizational , Motorcycles/economics , Patient Acceptance of Health Care/statistics & numerical data , Pregnancy Complications/therapy , Quality of Health Care/trends , Referral and Consultation/economics , Referral and Consultation/organization & administration , Risk Reduction Behavior , Rural Health Services/economics , Female , Humans , PregnancyABSTRACT
World population growth in the past century has taxed the ability of healthcare systems in low-income countries to provide reproductive health care. Maternal mortality and morbidity, sexually transmitted diseases, and cervical cancer are major problems. Expansion of reproductive health services, training of appropriate medical personnel, and elevating the status of women in society are all necessary and appropriate solutions to improve the health of women in low-income countries.
Subject(s)
Global Health , Women's Health , Developing Countries , Female , Humans , Maternal Health Services , Poverty AreasSubject(s)
Awards and Prizes , Gynecology , Obstetrics , Biomedical Research , Developing Countries , Female , Humans , Pregnancy , PublishingSubject(s)
Awards and Prizes , Gynecology , Obstetrics , Female , Gynecology/history , History, 21st Century , Humans , Obstetrics/history , Periodicals as Topic , Pregnancy , TaiwanSubject(s)
Gynecology , Obstetrics , Periodicals as Topic , Congresses as Topic , Female , Global Health , Humans , Societies, Medical , Women's HealthABSTRACT
Endometriosis is often a perplexing medical condition for both the physician and the patient. Accordingly, development of treatment strategies based on the needs of the individual patient is highly desirable. Although endometriosis has been part of the clinical practice for almost a century, many questions remain relating to the relationship between endometriosis and infertility as well as endometriosis and pelvic pain. Endometriosis is a disease of reproductive-age women, and it is now well recognized that a genetic susceptibility appears probable. The prevalence in the general population has never been clearly established. Factors to consider in management include the age and reproductive desires of the patient, the stage of the disease, and, most importantly, the symptoms. Therapeutic options include no treatment, medical therapy, surgery, or combination therapy. Oral contraceptives, androgenic agents, progestins, and gonadotropin releasing hormone (GnRH) analogs have all been used successfully, although at the present time, the latter preparations are the most popular medical therapy for endometriosis. Leuprolide acetate, goserelin acetate, and nafarelin acetate are all effective agents. Surgical therapy is appropriate, especially for advanced stages of the disease. Laparoscopy is an effective surgical approach with the goal of excision of visible endometriosis in a hemostatic fashion. Since endometriosis is a chronic condition, it is not uncommon for recurrences to occur. While endometriosis remains an enigmatic disease, the introduction of new pharmacologic agents, such as GnRH analogs and newer endoscopic methods of surgical treatment, have facilitated and improved the overall management of this disease.
Subject(s)
Endometriosis/therapy , Fertility Agents, Female/therapeutic use , Gonadotropin-Releasing Hormone/analogs & derivatives , Laparoscopy/methods , Pelvic Pain/therapy , Endometriosis/complications , Endometriosis/diagnosis , Female , Gonadotropin-Releasing Hormone/therapeutic use , Humans , Pain Measurement , Pelvic Pain/diagnosis , Pelvic Pain/etiology , Prognosis , Randomized Controlled Trials as Topic , Risk Assessment , Severity of Illness Index , Treatment OutcomeABSTRACT
OBJECTIVE: We describe a residency program in Ghana that was developed to train obstetrics/gynecologist specialists for Ghana and the subregion to promote and manage the reproductive health of women and to reduce a high maternal mortality rate. STUDY DESIGN: The Carnegie-supported program, begun in 1989, is a 5-year residency in the two medical schools in Ghana, but with one central coordinating office. It has features that equip the graduate resident to practice in his/her environment. The fourth year of the program is unique: the resident attends a hospital management course for 3 months, goes for a clinical rotation in the United States or United Kingdom for 3 months, and moves to live and work in a rural district hospital for 6 months. RESULTS: The success rate of the Ghanaian residents in the examination of the West African College of Surgeons has been three to four times higher than the overall pass rate. As of October 2002, the program had produced 26 specialists, all of whom are practicing in Ghana. In contrast, of 30 specialists who were trained abroad between 1960 and 1980, only 3 specialist had returned home by the end of the 1980s. The current chairpersons of the two medical schools are graduates of the program. Carnegie financial support for the program came to an end in January 2000, but the Ghana Ministry of Health has increased its support enthusiastically. The program is being sustained. Maternal mortality and morbidity rates are falling slowly in the two teaching hospitals; case fatality rates have been reduced markedly. New residents are entering the program and are progressing to completion. CONCLUSION: The program has been an unqualified success and merits replication.